| 1 |
34236726 | Effects of metformin on autoimmune immunoglobins and interferon-γ in patients with early diagnosed pemphigus vulgaris: a prospective clinical trial. | 2022 Jan |
1 |
| 2 |
33444083 | Increased metformin dosage suppresses pro-inflammatory cytokine levels in systemic circulation and might contribute to its beneficial effects. | 2021 May 4 |
1 |
| 3 |
34887262 | Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3. | 2021 Dec |
1 |
| 4 |
32533334 | Influences of preoperative metformin on immunological factors in early breast cancer. | 2020 Jul |
1 |
| 5 |
32641388 | Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Effector Functions and Activation-Induced Metabolic Reprogramming. | 2020 Aug 15 |
1 |
| 6 |
32646922 | Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. | 2020 Sep 15 |
1 |
| 7 |
30753544 | Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects. | 2019 Jun 5 |
1 |
| 8 |
31235122 | Association of glycemic status and interferon-γ production with leukocytes and platelet indices alterations in type2 diabetes. | 2019 May - Jun |
1 |
| 9 |
25673763 | Normalization of CD4+ T cell metabolism reverses lupus. | 2015 Feb 11 |
1 |
| 10 |
23744427 | Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance. | 2013 |
1 |
| 11 |
23107042 | Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. | 2012 Dec |
1 |
| 12 |
19494326 | Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. | 2009 Jun 15 |
1 |